These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37818169)

  • 1. Editorial: Digital therapeutics: using software to treat, manage, and prevent disease.
    Smayda KE; Campellone T; Taylor SR; Harris B; Ellis TD; Awad LN
    Front Digit Health; 2023; 5():1261124. PubMed ID: 37818169
    [No Abstract]   [Full Text] [Related]  

  • 2. Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical Pharmacology.
    Ribba B; Peck R; Hutchinson L; Bousnina I; Motti D
    Clin Pharmacol Ther; 2023 Sep; 114(3):578-590. PubMed ID: 37392464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital therapeutics in neurology.
    Abbadessa G; Brigo F; Clerico M; De Mercanti S; Trojsi F; Tedeschi G; Bonavita S; Lavorgna L
    J Neurol; 2022 Mar; 269(3):1209-1224. PubMed ID: 34018047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate controls for digital therapeutic clinical trials: A narrative review of control conditions in clinical trials of digital therapeutics (DTx) deploying psychosocial, cognitive, or behavioral content.
    Lutz J; Offidani E; Taraboanta L; Lakhan SE; Campellone TR
    Front Digit Health; 2022; 4():823977. PubMed ID: 36060538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital Therapeutics in Urology: An Innovative Approach to Patient Care and Management.
    Rodler S; Kowalewski KF; Scheibert H; Bensel M; Stadelmeier LF; Styn A; Belenchon IR; Taratkin M; Puliatti S; Gomez Rivas J; Veccia A; Piazza P; Checcucci E; Michel MS; Stief CG; Cacciamani G;
    Eur Urol Open Sci; 2023 Sep; 55():23-27. PubMed ID: 37593208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access and reimbursement pathways for digital health solutions and
    Mantovani A; Leopaldi C; Nighswander CM; Di Bidino R
    Front Med Technol; 2023; 5():1101476. PubMed ID: 36891483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining Diversity in Digital Therapeutics Clinical Trials: Descriptive Analysis.
    Adu-Brimpong J; Pugh J; Darko DA; Shieh L
    J Med Internet Res; 2023 Aug; 25():e37447. PubMed ID: 37531157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Evaluation of Digital Therapeutics: Present and Future.
    Huh KY; Oh J; Lee S; Yu KS
    Healthc Inform Res; 2022 Jul; 28(3):188-197. PubMed ID: 35982593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. There's an app for that, but nobody's using it: Insights on improving patient access and adherence to digital therapeutics in Germany.
    Dahlhausen F; Zinner M; Bieske L; Ehlers JP; Boehme P; Fehring L
    Digit Health; 2022; 8():20552076221104672. PubMed ID: 35811758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMCP Partnership Forum: The evolving role of digital therapeutics.
    J Manag Care Spec Pharm; 2022 Jul; 28(7):804-810. PubMed ID: 35699389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reimbursement of Digital Therapeutics: Future Perspectives in Korea.
    Ju JH; Sim B; Lee J; Lee JY
    Korean Circ J; 2022 Apr; 52(4):265-279. PubMed ID: 35388995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital therapeutics and clinical pharmacology.
    Chung JY
    Transl Clin Pharmacol; 2019 Mar; 27(1):6-11. PubMed ID: 32055575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software.
    Woo JH; Kim EC; Kim SM
    Expert Rev Med Devices; 2022 Mar; 19(3):213-228. PubMed ID: 35255755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Success Factors for Scaling Up the Adoption of Digital Therapeutics Towards the Realization of P5 Medicine.
    Prodan A; Deimel L; Ahlqvist J; Birov S; Thiel R; Toivanen M; Kolitsi Z; Kalra D
    Front Med (Lausanne); 2022; 9():854665. PubMed ID: 35492346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital Therapies (DTx) as New Tools within Physicians' Therapeutic Arsenal: Key Observations to Support their Effective and Responsible Development and Use.
    Bélisle-Pipon JC; David PM
    Pharmaceut Med; 2023 Mar; 37(2):121-127. PubMed ID: 36653600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first software as medical device of evidence-based hypertension digital therapeutics for clinical practice.
    Kario K; Harada N; Okura A
    Hypertens Res; 2022 Dec; 45(12):1899-1905. PubMed ID: 36207530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects on Adherence to a Mobile App-Based Self-management Digital Therapeutics Among Patients With Coronary Heart Disease: Pilot Randomized Controlled Trial.
    Li Y; Gong Y; Zheng B; Fan F; Yi T; Zheng Y; He P; Fang J; Jia J; Zhu Q; Jiang J; Huo Y
    JMIR Mhealth Uhealth; 2022 Feb; 10(2):e32251. PubMed ID: 34906924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of digital therapeutics.
    Hong JS; Wasden C; Han DH
    Comput Methods Programs Biomed; 2021 Sep; 209():106319. PubMed ID: 34364181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital Therapeutics in Hypertension: Evidence and Perspectives.
    Kario K; Harada N; Okura A
    Hypertension; 2022 Oct; 79(10):2148-2158. PubMed ID: 35726619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Game-based digital therapeutics for children and adolescents: Their therapeutic effects on mental health problems, the sustainability of the therapeutic effects and the transfer of cognitive functions.
    Choi E; Yoon EH; Park MH
    Front Psychiatry; 2022; 13():986687. PubMed ID: 36523871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.